Antimicrobial Acetimidamide Synthesis via One-Pot CDI Catalysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a growing need for new antimicrobial agents effective against drug-resistant microorganisms, and existing methods face challenges in synthesizing such compounds with high yields, efficient reaction times, and solvent-free processes using recyclable catalysts.

Innovation Solution

A 2-(benzo[d]oxazol-2-yl)-N′-(picolinoyloxy)acetimidamide compound is synthesized via a one-pot three-component reaction using (1,3-benzoxazol-2-yl)acetonitrile, 2-picolinic acid, and carbonyldiimidazole in acetonitrile, demonstrating excellent antimicrobial activity against various microbes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional synthesis methods are used to prepare antimicrobial compounds, then the compounds can be synthesized, but the yields are low and the process is time-consuming

Engineering Contradiction:
Improvesynthesis yieldVSAvoidreaction time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent combines three reactants ((1,3-benzoxazol-2-yl)acetonitrile, 2-picolinic acid, and carbonyldiimidazole) into a single reaction vessel to form the target compound through a one-pot three-component reaction. This merging of multiple steps into one operation directly increases synthesis yield (averaging 74%) while reducing the overall reaction time required for compound preparation.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

Carbonyldiimidazole (CDI) serves as a catalyst and intermediary agent in the reaction system. It facilitates the formation of the imidamide bond between the nitrile and carboxylic acid components, enabling the reaction to proceed efficiently under mild conditions. The catalyst mediates the transformation, improving both yield and reaction efficiency without requiring prolonged processing times.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If traditional synthesis approaches are employed, then compounds can be prepared, but solvent usage is required and catalyst recycling is difficult

Engineering Contradiction:
Improvesolvent-free processVSAvoidcatalyst recycling
Core Design Contradiction:
Ease of manufactureVSEase of repair

Solution Approach 1:

The patent extracts and eliminates the need for organic solvents from the synthesis process. The reaction is conducted in a solvent-free manner, where the reactants and catalyst interact directly without requiring external solvent media. This extraction of the solvent component simplifies the manufacturing process, reduces waste, and facilitates easier catalyst recycling and process cleanup.

Inventive Principle:
Principle #2Taking out (Extraction)

3Reliability

If new antimicrobial agents are designed and synthesized, then therapeutic activity is achieved, but the synthesis process becomes complex and difficult

Engineering Contradiction:
Improveantimicrobial activityVSAvoidsynthesis process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the synthesis process into distinct functional components: (1) the nitrile substrate providing the carbon framework, (2) the carboxylic acid providing the carbonyl group, and (3) the carbonyldiimidazole catalyst facilitating the coupling. This segmentation of functional roles allows each component to perform its specific function efficiently, achieving the target antimicrobial compound through a simplified, modular approach rather than a complex multi-step sequence.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The compound achieves satisfactory yields (about 74%) and exhibits strong antibacterial and antifungal activities against gram-positive and gram-negative bacteria, as well as fungi, providing a promising therapeutic option for microbial infections.

Implementation Method 1

using carbonyldiimidazole (CDI) as a catalyst

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS11905280B12-(benzo[d]oxazol-2-yl)-N'-(picolinoyloxy)acetimidamide as an antimicrobial compound
Publication Date: 2024.02.20 KING FAISAL UNIV
  • US11905280B1 patent drawing
  • US11905280B1 patent drawing
  • US11905280B1 patent drawing

AI summary

A 2-(benzo[d]oxazol-2-yl)-N′-(picolinoyloxy)acetimidamide compound, its synthesis, and its use as an antimicrobial agent.